Rose Ackermann
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 13
- Drug Solubulity and Delivery Systems 8
- Surgery 7
- Cholesterol and Lipid Metabolism 4
- Lipoproteins and Cardiovascular Health 4
- Co-authors
- Anna Schwendeman (15 shared papers)Karl Olsen (11 shared papers)Steven P. Schwendeman (13 shared papers)Jia Zhou (5 shared papers)Jennifer Walker (6 shared papers)Keiji Hirota (4 shared papers)Stephanie Choi (4 shared papers)Justin K. Y. Hong (6 shared papers)
- Journals
- Journal of Controlled Release (4 papers)Molecular Pharmaceutics (3 papers)Journal of Lipid Research (2 papers)Drug Delivery and Translational Research (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Rose Ackermann
29 papers receiving 993 citations
Peers
Comparison fields: 5 of 98
- Pharmaceutical Science 330
- Biomaterials 220
- Molecular Medicine 48
- Endocrinology, Diabetes and Metabolism 117
- Cancer Research 94
Countries citing papers authored by Rose Ackermann
This map shows the geographic impact of Rose Ackermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Ackermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Ackermann more than expected).
Fields of papers citing papers by Rose Ackermann
This network shows the impact of papers produced by Rose Ackermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Ackermann. The network helps show where Rose Ackermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Rose Ackermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 93 | |
| 2 | 2017 | 79 | |
| 3 | 2016 | 74 | |
| 4 | 2016 | 73 | |
| 5 | 2020 | 70 | |
| 6 | 2017 | 64 | |
| 7 | 2004 | 62 | |
| 8 | 2020 | 51 | |
| 9 | 2017 | 51 | |
| 10 | 2018 | 41 | |
| 11 | 2016 | 40 | |
| 12 | 2020 | 34 | |
| 13 | 2020 | 34 | |
| 14 | 2016 | 27 | |
| 15 | 2015 | 26 | |
| 16 | 2023 | 26 | |
| 17 | 2016 | 26 | |
| 18 | 2020 | 21 | |
| 19 | 2017 | 20 | |
| 20 | 2021 | 19 |
About Rose Ackermann
Rose Ackermann is a scholar working on Pharmaceutical Science, Surgery, Molecular Biology, Endocrinology, Diabetes and Metabolism and Biomaterials, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (13 papers), Drug Solubulity and Delivery Systems (8 papers), Nanoparticle-Based Drug Delivery (4 papers), Cholesterol and Lipid Metabolism (4 papers), Hydrogels: synthesis, properties, applications (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Mass Spectrometry Techniques and Applications (3 papers). The work is most often cited by research in Pharmaceutical Science (330 citations), Biomaterials (220 citations), Molecular Medicine (48 citations), Endocrinology, Diabetes and Metabolism (117 citations) and Cancer Research (94 citations). Rose Ackermann has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Anna Schwendeman, Karl Olsen, Steven P. Schwendeman, Jia Zhou, Jennifer Walker, Keiji Hirota, Stephanie Choi, Justin K. Y. Hong, Jie Tang and Amy C. Doty. Their work appears in journals such as Journal of Controlled Release, Molecular Pharmaceutics, Journal of Lipid Research, Drug Delivery and Translational Research and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.